-More detail on the nature of the simulation itself (e.g. the type of presenting problem) could be useful, perhaps in an appendix if necessary.
-Consider expanding discussion of how pharmacist/nurse antibiotic prescribing is different from that of general practitioners and why a separate training module is justified. pg 7 under Step 1 notes that pharmacists and nurses prescribe antibiotics inappropriately at times -does this occur at a similar rate as general practitioners (is this known)? Are the factors that drive inappropriate prescribing in pharmacists and nurses similar to or different than those for GPs? Or is it just a matter of changing the simulation "window dressing" regarding the simulated patient's presentation? -Regarding the simulation, it doesn't seem as if the participants are taking an active role in the prescribing encounter -rather, they are observing "good' and "bad" encounters and noting the differences. While this may be valuable, it would seem a more active role for the participants might lead to more robust learning -for example, a third scenario where the participant controls the actions of the simulated pharmacist/nurse to demonstrate application of the behaviors previously modeled.
-For a pilot study the outcomes of qualitative interview and prepost Likert items are appropriate, but as a reader I would be more interested in how a "real-world" intervention of the completed tool would be studied. Would the actual prescribing patterns of participants for URTIs be studied? With a randomized design, prepost, etc? Without a glimpse into how this tool might be ultimately deployed, it seems a little inconsequential to report the design of a study piloting its design, since many studies of similar medical simulations have previously been published. Consider adding some forward-looking statements about how the tool might be deployed and studied after its "validation".
REVIEWER
Anna Sallis Public Health England, England REVIEW RETURNED 21-Mar-2019
GENERAL COMMENTS
The intervention proposed is much needed but the paper doesn't really describe the intervention in any depth nor is there enough detail on the methodology for the methods to be replicated. The feasibility study lacks sophistication in methods for understanding how users interact with online training/an app whichever this is. There is no discussion of criteria for determining whether a full RCT goes ahead or how the results will feed into intervention improvement.
The abstract talks about appropriate prescribing but then in the strengths and limitations summary it suddenly switches to talk about no prescribing.
What are 'naturally occurring BCTs?' mentioned in the strengths and limitations -maybe it will become clear as I read on.
p5/18 -a reference for line 26 would be good. p8/9
Step 5 this whole section needs much more detail and clarity to follow the methodology. Same for stages 6 & 7.
p10 The TIDIER reporting framework was used to describe the intervention but I am still left wanting to see this and understand what this intervention looks like.
Step This has now been amended Page 10, line 52: the format and compatibility of the e-learning module could be better described.
Given that the implication is that it is platform agnostic, is it indeed a web-based e-learning package, in which case the module is not really 'downloaded' but 'accessed'. While a minor technicality, with digital health being so important right now, the development and accessibility of the module itself is of relevance to this paper and the evidence-base.
This has now been amended Reviewer 2 The paper adequately describes the methodology used in the design of the tool from a theoretical perspective.
We thank the reviewer for this comment
More detail on the nature of the simulation itself (e.g. the type of presenting problem) could be useful, perhaps in an appendix if necessary.
The following have been made clear under step 8: -That the presenting problem is a common, acute, uncomplicated self-limiting RTIs.
-
The timing of the animation It has also been made clear under 'Electronic learning activity' that the intervention targets the 12 domains described in Stage 1, step 4 .
Consider expanding discussion of how pharmacist/nurse antibiotic prescribing is different from that of general practitioners and why a separate training module is justified. pg 7 under
Step 1 notes that pharmacists and nurses prescribe antibiotics inappropriately at timesdoes this occur at a similar rate as general practitioners (is this known)? Are the factors that drive inappropriate prescribing in pharmacists and nurses similar to or different than those for GPs? Or is it just a matter of changing the simulation "window dressing" regarding the simulated patient's presentation?
This has now been addressed under stage 1, step 1.
Regarding the simulation, it doesn't seem as if the participants are taking an active role in the prescribing encounter -rather, they are observing "good' and "bad" encounters and noting the differences. While this may be valuable, it would seem a more active role for the participants might lead to more robust learning -for example, a third scenario where the participant controls the actions of the simulated pharmacist/nurse to demonstrate application of the behaviors previously modeled.
In order to stimulate active learning, users are presented at various points throughout the animation with a variety of interactions that focus the user's attention on the differences between the 2 consultations. Points are scored for each correct answer. This was not described in the first draft of our paper and has now been made clear.
For a pilot study the outcomes of qualitative interview and pre-post Likert items are appropriate, but as a reader I would be more interested in how a "real-world" intervention of the completed tool would be studied. Would the actual prescribing patterns of participants for URTIs be studied? With a randomized design, pre-post, etc? Without a glimpse into how this tool might be ultimately deployed, it seems a little inconsequential to report the design of a
We have included additional information under 'Ethics and dissemination' that if a positive outcome is found at this stage, any suitable amendments will be made, and the work will move to a pilot and cluster randomised controlled trial to evaluate whether or not the intervention may be used to support appropriate antibiotic prescribing for self-limiting RTIs by nurse and pharmacist prescribers. study piloting its design, since many studies of similar medical simulations have previously been published. Consider adding some forward-looking statements about how the tool might be deployed and studied after its "validation".
Reviewer 3
The intervention proposed is much needed but the paper doesn't really describe the intervention in any depth nor is there enough detail on the methodology for the methods to be replicated. The feasibility study lacks sophistication in methods for understanding how users interact with online training/an app whichever this is .There is no discussion of criteria for determining whether a full RCT goes ahead or how the results will feed into intervention improvement.
The intervention has now been described in greater detail under step 8. Further details have also been added to each of the three-stages eight steps that describe intervention development process. A table (supplementary Table 1 ) is now included in our submission, which clearly shows the links between COM-B model, TDF domains, intervention functions, policy categories and BCTs alongside intervention content and mode of delivery. It has been made clearer under 'procedure and data collection' for the feasibility study that the interview topic guide will address each component of the COM-B model to gain insights into the key issues associated with the specific mechanisms through which the intervention operates and the barriers and enablers to its uptake. Further information has been provided under 'Ethics and dissemination' re criteria for determining whether or not a full RCT goes ahead, and how results will feed into intervention improvement.
This has been amended
The 'Strengths and limitations' section has been amended and the words 'naturally occurring BCTs' removed. Naturally occurring BCTs are further described under stage 3, step 7. This has been amended p8/9
Further detail has been added to these sections. In additions, a table has been provided (supplementary Table 1 A fuller description of the intervention (including further information about intervention content and mode of delivery) has been added to step 8. Table 1 also provides this information clearly linking it to BCTs, intervention functions, policy categories COM-B model, TDF domains.
Step 8 -unclear how the described components relate to the interview study, analysis of IF and PC and how BCTs are linked and I am still not sure what is meant by naturally occurring BCTs.
A table has been provided (supplementary Table 1 ) that clearly link the described components to the interview study, IFs PC, and BCTs. Naturally occurring BCTs have been further explained under stage 3, step 7. p11 Participants. I am not sure a national sample can be claimed for 12-15 individualsNeeds rewording. It would also be better to test this with a new sample not the ones who already took part in the previous research.
The word national has been removed. We have also made it clear that if there are insufficient participants, members of the research team (KH and RL) will approach key contacts in their existing nurse and pharmacist prescriber networks to help with recruitment. P11 -so is this an e-learning app if it can be downloaded? There doesn't seem to be any discussion of digital intervention development and how to ensure user engagement and interviews using user centred design approaches. To optimise digital intervention content it may be better to sit with the participants and watch them use it or collect some data on how the app is being used and what features are used or not used or need to be optimised.
The importance of user engagement in interventions that employ digital technologies has been highlighted under 'Procedure and data collection'. It has also been made clearer that the semi-structured interview data we will collect, will include information on how the features of the intervention are used.
Analysis -how many people is the survey going to? Are percentages useful?
It has been made clear under 'Recruitment' that all participants will be invited to participate in the on-line questionnaire survey and a semistructured interview. We plan to do a descriptive analysis and so % will be useful.
VERSION 2 -REVIEW

REVIEWER
Conan MacDougall University of California San Francisco School of Pharmacy, United States of America
REVIEW RETURNED
28-May-2019
GENERAL COMMENTS
This revision addresses the (minor) concerns from the prior submission and is as comprehensive a description of the study as a journal publication would allow. Best of luck on executing the study.
REVIEWER
Anna Sallis Public Health England England REVIEW RETURNED
23-May-2019
GENERAL COMMENTS
There are still a number of improvements in terms of clarity and writing which can be made to this paper. The two aims should be separated throughout the paper -intervention design and feasibility testing. The paper and methods for feasibility testing lack sophistication in terms of engagement in digital behaviour change intervention (DBCI) design and evaluation. A few examples papers attached which could be read and ideas included in revised design for feasibility study.
https://www.ucl.ac.uk/behaviourchange/pdfs/resources/evaluatingdigihealth.pdf https://www.jmir.org/2017/6/e232/ https://journals.sagepub.com/doi/10.1177/2055207618770325
The reviewer also provided a marked copy with additional comments. Please contact the publisher for full details.
VERSION 2 -AUTHOR RESPONSE
Response to reviewers' comments:
Reviewer 3 Response
There are still a number of improvements in terms of clarity and writing which can be made to this paper. The two aims should be separated throughout the paper -intervention design and feasibility testing..
The two aims have been made clear in the 'Abstract' and at the end of the 'Introduction'.
Two additional headings have also been added under 'Methods and analysis' (Intervention development and acceptability and feasibility study) to make this clearer Split this into methods and analysis for intervention development and then separately for the feasibility study.
The paper and methods for feasibility testing lack sophistication in terms of engagement in digital behaviour change intervention (DBCI) design and evaluation. A few examples papers attached which could be read and ideas included in revised design for feasibility study.
We thank the reviewer for this very helpful comment and the links to the relevant literature. Further information has been included under the section now headed 'Acceptability and feasibility study' to address this.
Title very long now. I'm not clear what is meant by independent prescriber -is that needed in the title? Suggested improvement?
A theory-based electronic learning intervention to support appropriate antibiotic prescribing by nurses and pharmacists: Intervention development and feasibility study protocol
We have removed the word 'independent' from the title. The title has also been shortened inline with the suggested title.
This section is really unclear. Separate into two sub-sections for the two aims.
So the feasibility study consists of semistructured interviews after the practitioner has used the intervention? And a pre-post survey of intervention use. The outcome variable being measured is knowledge? What else is measured to determine feasibility and acceptability.
We have included two sub-sections and clarified what each consists of, to make the method and analysis section clearer.
It has been made clear both in the abstract and under the sub section 'Acceptability and feasibility study' that semi-structured interviews will capture information about how the user reacts to the design, delivery and content of the intervention and influences on understanding and engagement. The pre-post questionnaire will measure knowledge, confidence and usefulness in terms of application to practice. This has been made clear.
Not sure what this means assigning codes? Do you mean themes? Then the themes will be mapped to COM-B to determine whether they had any capability, opportunity or motivational issues with the use of the intervention? What is the survey asking about? Is that structured around COM-B?
We have clarified this further in the text to: Taking an initial inductive approach, data from interview transcript will coded and then analysed to derive themes. These themes will then be deductively mapped to the Capability, Opportunity, Motivation-Behaviour (COM-B) model. The proposed intervention content and mode of delivery was mapped from COM-B to the TDF, intervention functions and policy categories (based on Cane et al., 2012 and Michie et al., 2014) , with BCTs selected as the most appropriate targets for the proposed intervention content drawn from pre-development interviews and based on Michie et al., (2013; 2014) and Cane et al., (2015) which have previously mapped the most appropriate and commonly used BCTs for each TDF domain and Intervention function.
Amend behaviout to behaviour
We have corrected the typo.
All intervention functions and policy categories matched to the TDF or are these proposed content?
These are the proposed intervention functions and policy categories matched to the TDF content from the pre-development interviews and linked to the proposed intervention content. We have clarified this sentence making it clear that the electronic learning activity, comprised a typical consultation scenario.
The clarity of this whole section could be improved. State upfront the animation had two parts showing a bad and a good consultation.
We have clarified the whole section by making clear reference to a congruent and noncongruent consultation. We avoided the term bad as many practitioners use the first approach in practice and the term bad has negative connotations. We therefore have linked to a congurent (or not) approach for a nonprescribing decision Now you are describing the planned feasibility study and have finished describing the intervention -this should be labeled as a new sub-section.
We have now included a new sub-section to make clear that the participants here refers to the planned feasibility study.
of each? Minimum number of each?
The maximum number of participants include both nurse and pharmacist independent prescribers working in primary care.
I'm no expert in this but feel sure there is something more appropriate than COM-B to assess user engagement in digital interventions. It is a shame that the researcher cannot observe the participant interacting with the intervention and ask the questions sooner than 2 weeks later.
The topic guide will also include questions around usability of the intervention, "A topic guide will address each component of the COM-B model to gain insights into the key issues associated with the specific mechanisms through which the intervention operates, and the barriers and enablers to its uptake including its usability, in terms of how easy it was to use the intervention."
We expect to conduct interviews no later than 2 weeks after participants have used the intervention.
The reviewer also raised a really important point about observing participants use the electronic intervention from a usability point of view. We have considered the feasibility of conducting such observations, and balanced it with how/when the intervention was designed to be used ie on any device (personal or work) in their chosen time (work, break, home, day off) -our experience of such studies indicate that scheduling a visit to observe their use of the 5-minute electronic intervention in their own time, will likely reduce participation. This is a limitation to the study which we acknowledge.
Can you make this -this is completed immediately pre-post intervention?
We have added your suggestion and it now reads:
Using an on-line questionnaire design completed before and immediately after the intervention,… Exact timing of survey administration and state this is pre-post at start of this section.
We have edited the text to clearly indicate the timing and content of the pre and postintervention questionnaires.
Is it really worth having a pre-post design for 12 -15 participants?
We are keen to gain insights into the intervention with regards to its effects on knowledge and confidence. The pre-post questionnaire will enable us to identify any emerging trends I'm not sure you can predict that its benefits will be clinically meaningful until after the full RCT
We have edited the text to read:
Once we are confident that the intervention can be implemented with high fidelity, that any future developments can be considered relatively minor, and that it lead to improved outcomes,
